AIRLINK 72.00 Decreased By ▼ -2.10 (-2.83%)
BOP 5.01 Increased By ▲ 0.01 (0.2%)
CNERGY 4.40 Increased By ▲ 0.06 (1.38%)
DFML 29.18 Decreased By ▼ -0.36 (-1.22%)
DGKC 83.20 Decreased By ▼ -0.35 (-0.42%)
FCCL 22.35 Decreased By ▼ -0.08 (-0.36%)
FFBL 34.37 Decreased By ▼ -0.53 (-1.52%)
FFL 10.13 Increased By ▲ 0.26 (2.63%)
GGL 10.22 Increased By ▲ 0.22 (2.2%)
HBL 113.40 Increased By ▲ 1.40 (1.25%)
HUBC 141.25 Increased By ▲ 3.56 (2.59%)
HUMNL 8.03 Increased By ▲ 1.05 (15.04%)
KEL 4.43 Increased By ▲ 0.03 (0.68%)
KOSM 4.51 Decreased By ▼ -0.08 (-1.74%)
MLCF 38.41 Decreased By ▼ -0.14 (-0.36%)
OGDC 135.25 Decreased By ▼ -1.35 (-0.99%)
PAEL 26.86 Increased By ▲ 1.72 (6.84%)
PIAA 25.94 Decreased By ▼ -0.57 (-2.15%)
PIBTL 6.53 Decreased By ▼ -0.12 (-1.8%)
PPL 122.89 Decreased By ▼ -2.51 (-2%)
PRL 28.17 Decreased By ▼ -0.04 (-0.14%)
PTC 13.97 Decreased By ▼ -0.33 (-2.31%)
SEARL 55.64 Increased By ▲ 1.04 (1.9%)
SNGP 70.40 Decreased By ▼ -0.80 (-1.12%)
SSGC 10.49 Decreased By ▼ -0.01 (-0.1%)
TELE 8.62 Increased By ▲ 0.10 (1.17%)
TPLP 11.06 Increased By ▲ 0.12 (1.1%)
TRG 61.55 Increased By ▲ 0.85 (1.4%)
UNITY 25.28 Decreased By ▼ -0.05 (-0.2%)
WTL 1.29 Increased By ▲ 0.03 (2.38%)
BR100 7,665 Increased By 0.1 (0%)
BR30 25,140 Increased By 114.2 (0.46%)
KSE100 73,153 Increased By 388.3 (0.53%)
KSE30 23,757 Decreased By -18.3 (-0.08%)
Business & Finance

EU preparing orders for 1.8bn vaccine booster shots

  • The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
  • Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.
Published April 9, 2021

BERLIN: The European Union will shortly sign contracts to purchase up to 1.8 billion doses of coronavirus vaccine to cover the bloc's need for booster shots over the coming two years, German daily Die Welt reported on Friday.

The newspaper said that contracts would be signed for deliveries of 900 million doses, with further contracts creating an option for another 900 million doses to be bought. The planned purchases would also cover the 70-80 million children in the EU, who are not currently being vaccinated.

The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.

Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.

Comments

Comments are closed.